April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
City of Hope to participate in NCI-MATCH clinical trial
April 5, 2019 | City of Hope
City of Hope’s Clinical Molecular Diagnostic Laboratory (CMDL) is participating as a CLIA-Certified/Accredited laboratory in the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine trial.
Diagnosis and treatment at the same time? With theranostics, it's possible
March 27, 2019 | Zen Vuong
A City of Hope scientist and his colleagues have developed a user-friendly approach to creating “theranostics” — therapy combined with diagnostics — that target specific tumors and diseases.
Big data for better results: the power and the promise of precision medicine
September 26, 2018 | Sam Lazaryev
Jeff Trent, Ph.D., TGen president and research director, discusses the promise of precision medicine and his company’s exciting initiative with City of Hope.
City of Hope's Ravi Salgia Discovers New Biomarker Link in Nonsmall Cell Lung Cancer
December 7, 2017 | Elise Lamar
Ravi Salgia, M.D., Ph.D., recently published in Scientific Reports about a novel and promising link between two NSCLC biomarkers. The study might help oncologists match patients with effective drug interventions against specific forms of NSCLC.
Custom Care: Personalized Treatment for Breast Cancer
July 21, 2017 | City of Hope
The term “personalized” gets used a lot in medicine these days. If you’ve received a breast cancer diagnosis, you’re probably wondering what personalized breast cancer care really means.
Targeted Therapy 101: A Primer
July 17, 2017 | City of Hope
Cancer care has come a long way. Surgery, chemotherapy and radiation have traditionally been the three pillars of cancer care, and they are still important treatments. But in recent years, newer “targeted therapies” have come on the scene.
City of Hope collaborates with The Jackson Laboratory to help speed research discoveries into cures
July 11, 2017 | Denise Heady
A collaboration with The Jackson Laboratory expands access to leading-edge research capabilities to find new treatments for life-threatening diseases.
Liquid Biopsy Offers a New Way to Target Kidney Cancer
February 17, 2017 | Denise Heady
Despite a wave of new targeted therapies being approved to treat kidney cancer, many of those therapies have been challenging to use because of the difficulty in obtaining cancer tissue for genomic testing. Now, researchers may have found a way to combat this problem: the liquid biopsy.
Advances: New Immunotherapy Treatments for Breast Cancer in 2017
December 23, 2016 | Katie Neith
Peter P. Lee, M.D., a City of Hope oncologist, has for 20 years been interested in treating cancer by stimulating or enhancing a person’s own immune system. This approach, called immunotherapy, has gained much attention in recent years. Lee's outlook for 2017 is full of promise for a more personalized approach to the disease.